Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Inflammatory Bowel Diseases

  Free Subscription


25.05.2020

5 Aliment Pharmacol Ther
1 BMC Gastroenterol
2 Clin Gastroenterol Hepatol
1 Dig Dis Sci
1 Gastroenterol Hepatol
5 Gastroenterology
4 Inflamm Bowel Dis
1 J Crohns Colitis
1 Lancet Gastroenterol Hepatol
1 Z Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. ALBSHESH A, Ben-Horin S
    Editorial: which biologic is next for ulcerative colitis patients who fail a subcutaneous anti-TNF?
    Aliment Pharmacol Ther. 2020;51:1198-1199.
    PubMed        

  2. SANDBORN WJ, Panes J, Sands BE, Reinisch W, et al
    Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply.
    Aliment Pharmacol Ther. 2020;51:1209-1210.
    PubMed        

  3. SANTA A, Szanto KJ, Sarlos P, Miheller P, et al
    Letter: suicide risk among adult inflammatory bowel disease patients.
    Aliment Pharmacol Ther. 2020;51:1213-1214.
    PubMed        

  4. KOTZE PG, Teixeira FV, Damiao AOMC
    Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice.
    Aliment Pharmacol Ther. 2020;51:1208-1209.
    PubMed        

  5. MALHAM M, Jakobsen C, Paerregaard A, Hald M, et al
    Letter: suicide risk among adult inflammatory bowel disease patients. Authors' reply.
    Aliment Pharmacol Ther. 2020;51:1214-1215.
    PubMed        


    BMC Gastroenterol

  6. CHO B, Yoon SM, Son SM, Kim HW, et al
    Ischemic colitis induced by indigo naturalis in a patient with ulcerative colitis: a case report.
    BMC Gastroenterol. 2020;20:154.
    PubMed         Abstract available


    Clin Gastroenterol Hepatol

  7. DULAI PS, Sandborn WJ, Murphy J
    Microsimulation Model to Determine the Cost Effectiveness of Treat to Target Strategies for Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 May 10. pii: S1542-3565(20)30644.
    PubMed         Abstract available

  8. MELNYK J, Stefanov DG, Sultan K
    Inflammatory Bowel Disease and Corticosteroid induced Diabetes Mellitus.
    Clin Gastroenterol Hepatol. 2020 May 17. pii: S1542-3565(20)30678.
    PubMed        


    Dig Dis Sci

  9. GUTIN LS, Lam AY, Velayos FS, Santos SA, et al
    Going Viral: Management of IBD in the Era of the COVID-19 Pandemic.
    Dig Dis Sci. 2020;65:1571-1575.
    PubMed        


    Gastroenterol Hepatol

  10. MARIN-JIMENEZ I, Zabana Y, Rodriguez-Lago I, Marin L, et al
    [COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020)].
    Gastroenterol Hepatol. 2020 May 15. pii: S0210-5705(20)30138.
    PubMed         Abstract available


    Gastroenterology

  11. KOTZE PG, Peyrin-Biroulet L, Danese S
    Balancing risks and benefits in inflammatory bowel disease patients during the COVID-19 pandemic.
    Gastroenterology. 2020 May 15. pii: S0016-5085(20)30660.
    PubMed        

  12. SONDHI AR, Nayak LJ, Mowers J
    Cachexia, Colitis, and Cancer.
    Gastroenterology. 2020;158:488-490.
    PubMed        

  13. D'HAENS G, Kelly O, Battat R, Silverberg MS, et al
    Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins.
    Gastroenterology. 2020;158:515-526.
    PubMed         Abstract available

  14. BHAT S, Farraye FA, Moss A
    Roles of Clinical Pharmacists in Caring for Patients with Inflammatory Bowel Disease during COVID-19.
    Gastroenterology. 2020 May 18. pii: S0016-5085(20)30677.
    PubMed        

  15. MITSIALIS V, Wall S, Liu P, Ordovas-Montanes J, et al
    Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
    Gastroenterology. 2020 May 16. pii: S0016-5085(20)30658.
    PubMed         Abstract available


    Inflamm Bowel Dis

  16. MINTZ MJ, Ananthakrishnan AN
    Phenotype and Natural History of Inflammatory Bowel Disease in Patients With Concomitant Eosinophilic Esophagitis.
    Inflamm Bowel Dis. 2020 May 20. pii: 5840920. doi: 10.1093.
    PubMed         Abstract available

  17. YU A, Friedman S, Ananthakrishnan AN
    Characteristics and Long-Term Outcomes of Pregnancy-Onset Inflammatory Bowel Disease: A Case-Control Study.
    Inflamm Bowel Dis. 2020 May 19. pii: 5840482. doi: 10.1093.
    PubMed         Abstract available

  18. EGBERG MD, Phillips M, Galanko JA, Kappelman M, et al
    Total Abdominal Colectomies With Proctectomy Are Associated With Higher 30-Day Readmission Rates in Children With Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 May 19. pii: 5840483. doi: 10.1093.
    PubMed         Abstract available

  19. DRAGONI G, De Hertogh G, Vermeire S
    The Role of Citrullination in Inflammatory Bowel Disease: A Neglected Player in Triggering Inflammation and Fibrosis?
    Inflamm Bowel Dis. 2020 May 19. pii: 5840491. doi: 10.1093.
    PubMed         Abstract available


    J Crohns Colitis

  20. PARK SH, Kim HJ, Lee CK, Song EM, et al
    Safety and optimal timing of BCG vaccination in infants born to mothers receiving anti-TNF therapy for inflammatory bowel disease.
    J Crohns Colitis. 2020 May 17. pii: 5838422. doi: 10.1093.
    PubMed         Abstract available


    Lancet Gastroenterol Hepatol

  21. IACUCCI M, Cannatelli R, Labarile N, Mao R, et al
    Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period.
    Lancet Gastroenterol Hepatol. 2020 Apr 16. pii: S2468-1253(20)30119.
    PubMed         Abstract available


    Z Gastroenterol

  22. THOMANN AK, Schulte LA, Globig AM, Hoffmann P, et al
    Ustekinumab serum concentrations are associated with clinical outcomes in Crohn's disease - a regional multi-center pilot study.
    Z Gastroenterol. 2020;58:439-444.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: